Journals / European Archives of Medical Research / 2019 / Cilt: 35 - Sayı: 4

Age-related Differences in Homocysteine and Serological Markers in Patients with Sudden Sensorineural Hearing Loss

Pages
197–200
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Homocysteine and C3 levels are valuable but agerelatedparameters following diagnosis and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Sudden hearing loss is mostly a unilateral sensorineural hypoacusis with the highest incidence in young adults.
📊
Key Findings & Data:The aim of this study was to determine thedifferences in homocysteine and serological marker levels in sudden sensorineural hearing loss and to define the importance of these markers in diagnosis.Methods: After audiological examination, 52 patients were considered as having sudden hearing loss.
💡
Conclusion & Impact:Homocysteine and C3 levels are valuable but agerelatedparameters following diagnosis and treatment.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Sudden hearing loss is mostly a unilateral sensorineural hypoacusis with the highest incidence in young adults. The aim of this study was to determine thedifferences in homocysteine and serological marker levels in sudden sensorineural hearing loss and to define the importance of these markers in diagnosis.Methods: After audiological examination, 52 patients were considered as having sudden hearing loss. Serological markers (C3, C4, anti-streptolysin-O, C-reactive protein,rheumatoid factor) and homocysteine were examined. The patients were divided into two groups, as patients above and below 40 years of age. Statistical analysis wasperformed using SPSS version 15 software. P values less than 0.05 were considered statistically significant.Results: Fifty-two patients were included in the study, and the study group consisted of 33 men and 19 women. The mean age was 43.5 years and the age range was14-82 years. According to the survey results, 63% of the patients had higher than normal homocysteine levels. It was observed that 60.8% of homocysteine levels wereincreased in patients below 40 years of age and 69% in patients over 40 years of age. There was no statistically significant difference between the two groups (p=0.49).In the evaluation of immunological serological markers, no parameter was observed except for C3c. Fifty-four percent of all patients were considered to have a C3cparameter below normal limits. C3c levels were decreased in 52% of patients below 40 years of age and 55% of patients over 40 years of age. There was no statisticallysignificant difference between the two groups (p=0.31).Conclusion: It is thought that microvascular and immunological pathogenesis develops in sudden hearing loss. Homocysteine and C3 levels are valuable but agerelatedparameters following diagnosis and treatment.

🔖

Cite This Article

AŞIK, M. B. (2022). Age-related Differences in Homocysteine and Serological Markers in Patients with Sudden Sensorineural Hearing Loss. European Archives of Medical Research, Cilt: 35 - Sayı: 4, 197–200. https://ajindex.com/articles/510419

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cadoni G, Scorpecci A, Cianfrone F, Giannantonio S, Paludetti G, Lippa S. Serum fatty acids and cardiovascular risk factors in sudden sensorineural hearing loss: a case-control study. Ann Otol Rhinol Laryngol 2010;119:82-8
  2. Enache R, Sarafoleanu C. Prognostic factors in sudden hearing loss. J Med Life 2008;1:343-7
  3. Zhang X, Xu X, Ma W, Zhang Q, Tong B, Yu H, et al. A clinical study of sudden deafness. Acta Otolaryngol 2015;135:1030-5
  4. Wei X, He J. Analysis of prognostic factors for sudden sensorineural hearing loss. Lin Chung Erb Bi Yan Hou Tou Jing Wai Ke Za Zhi 2011;25:599-601
  5. Lasisi AO, Arinola AG. Acute Phase Reactants in Immune-Related Inner Ear Disease. Afr J Biomed Res 2010;13:113-7
  6. Suckfüll M. Perspectives on the Pathophysiology and Treatment of sudden Idiopathic Sensorineural Hearing Loss. Dtsch Arztebl Int 2009;106:669-76
  7. Greco A, Fusconi M, Gallo A, Marinelli C, Macri GF, De Vincentis M. Sudden Sensorineural Hearing Loss: An Autoimmune Disease ?. Autoimmun Rev 2011;756-61
  8. Werneck A, Gurgel L, Mello L, Albuquerque G. Sudden Sensorineural Hearing Loss: A Case Report Supporting the Immunologic Theory. Arq Neuropsiquiatr 2003;61:1018-22
  9. Wilson H, Alderson DJ. Sudden Sensorineural Hearing Loss: When is it Idiopatic?. J Laryngol Otol 2010;124:690-3
  10. Toubi E, Ben-David J, Kessel A, Halas K, Sabo E, Luntz M. Immune-mediated Disorders Associated with Idiopathic Sudden Sensorineural Hearing Loss. Ann Otol Rhinol Laryngol 2004;113:445-9
  11. Berrocal JR., Camacho-Ramirez R. Sudden Sensorineural Hearing Loss: Supporting the Immunologic Theory. Ann Otol Rhinol Laryngol 2002;111:989-97
  12. Ay M, Gürbilen M, Vatansev H. Akut Faz Proteinleri. Gen Tıp Der 1998;8:124- 32
  13. Marcucci R, Alessandrello Liotta A, Cellai AP, Rogolino A, Berloco P, Leprini E, et al. Cardiovascular and Thrombophilic Risk Factors for Idiopathic Sudden Sensorineural Hearing Loss. J Thromb Haemost 2005;3:929-34
  14. Oh JH, Park K, Lee SJ, Shin YR, Choung YH. Bilateral versus Unilateral Sudden Sensorineural Hearing Loss. Otolaryngol Head Neck Surg 2007;136:87-91.